Evidence map›Paper›PMID 38958152›Full record

ArticleJournal of the American Heart Association2024

High-Density Lipoprotein Particle Concentration and Size Predict Incident Coronary Artery Disease Events in a Cohort With Type 1 Diabetes.

Tina Costacou, Tomas Vaisar, Rachel G Miller, W Sean Davidson, Jay W Heinecke, Trevor J Orchard, Karin E Bornfeldt

Abstract read
In one paragraph

Article in Journal of the American Heart Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Effects of aged black garlic (ABG10+Frontiers in nutrition · 2026
    Trial
  2. Review
  3. Article
  4. Review
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tina CostacouDepartment of Epidemiology University of Pittsburgh Pittsburgh PA.ORCID 0000-0001-9303-3810
Tomas VaisarDepartment of Medicine University of Washington Seattle WA.ORCID 0000-0002-7406-6606
Rachel G MillerDepartment of Epidemiology University of Pittsburgh Pittsburgh PA.ORCID 0000-0003-1845-8477
W Sean DavidsonDepartment of Pathology and Laboratory Medicine University of Cincinnati College of Medicine Cincinnati OH.ORCID 0000-0003-2756-2989
Jay W HeineckeDepartment of Medicine University of Washington Seattle WA.ORCID 0000-0001-5246-0007
Trevor J OrchardDepartment of Epidemiology University of Pittsburgh Pittsburgh PA.ORCID 0000-0001-9552-3215
Karin E BornfeldtDepartment of Medicine University of Washington Seattle WA.ORCID 0000-0001-9208-6523

Funding

Vector and Transgenic Mouse CoreP30DK017047 · NIDDK · UNIVERSITY OF WASHINGTON · PI Sakeneh Zraika · 1986 to 2026
$41.4M
Project 3 - HDL Structure/Function in LCAT Deficient HumansP01HL128203 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI W Sean Davidson · 2016 to 2026
$25.1M
Triglycerides, Diabetes and Cardiovascular DiseaseP01HL151328 · NHLBI · UNIVERSITY OF WASHINGTON · PI Karin E Bornfeldt · 2020 to 2026
$19.6M
Identifying new strategies for prevention of cardiovascular complications of diabetesR35HL150754 · NHLBI · UNIVERSITY OF WASHINGTON · PI BORNFELDT, KARIN E · 2020 to 2025
$6.2M
EPIDEMIOLOGY OF DIABETIC COMPLICATIONS--PHASE IIR01DK034818 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI COSTACOU, TINA · 1986 to 2019
$5.6M
Apolipoprotein C3-loading of apolipoprotein B100 lipoproteins and cardiovascular disease in patients with type 1 diabetesR01HL161829 · NHLBI · UNIVERSITY OF WASHINGTON · PI HEINECKE, JAY W · 2022 to 2025
$3.3M
HDL composition/function and cardiovascular risk in youths with diabetesR01HL144558 · NHLBI · UNIVERSITY OF WASHINGTON · PI VAISAR, TOMAS · 2019 to 2022
$2.8M
Structural basis for cardioprotective HDLR01HL149685 · NHLBI · UNIVERSITY OF WASHINGTON · PI BORNFELDT, KARIN E., HEINECKE, JAY W · 2020 to 2023
$2.8M
Re-evaluating the role of HDL in coronary artery disease (RETRO HDL)R01HL130153 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI COSTACOU, TINA · 2016 to 2019
$2.0M
NHLBI NIH HHS P01 HL128203NHLBI NIH HHS P01 HL151328NHLBI NIH HHS R01 HL130153NHLBI NIH HHS R01 HL144558NHLBI NIH HHS R01 HL149685NHLBI NIH HHS R01 HL161829NHLBI NIH HHS R35 HL150754NIDDK NIH HHS P30 DK017047NIDDK NIH HHS R01 DK034818
6 · The paper itself

Abstract

backgroundThe cholesterol efflux capacity of high density lipoprotein (HDL) is negatively associated with cardiovascular risk. Small HDL particles account almost quantitatively for cholesterol efflux capacity, perhaps mediated through efflux of cholesterol and outer leaflet plasma membrane phospholipids by ABCA1 (ATP binding cassette subfamily A member 1). People with type 1 diabetes are at increased coronary artery disease (CAD) risk despite normal HDL-cholesterol concentrations. We therefore tested the hypothesis that small HDL particles (HDL-P)-rather than HDL-cholesterol-predict incident CAD in type 1 diabetes. METHODS AND

resultsIncident CAD (CAD death, myocardial infarction, or coronary revascularization) was determined in 550 individuals with childhood-onset type 1 diabetes. HDL-P was quantified by calibrated ion mobility analysis and cholesterol efflux capacity was quantified with validated assays. During a median follow-up of 26 years, 36.5% of the participants developed incident CAD, for an incidence density of 181.3 per 10 000 person-years. In multivariable Cox models, neither HDL-cholesterol nor apolipoprotein A1 concentration was significantly associated with CAD risk. In contrast, higher extra-small HDL-P concentrations were significantly associated with decreased CAD risk (hazard ratio [HR], 0.26 [95% CI, 0.14-0.50]). Weaker associations were observed for total HDL-P (HR, 0.88 [95% CI, 0.83-0.93]), small HDL (HR, 0.83 [95% CI, 0.68-1.02]), medium HDL (HR, 0.79 [95% CI, 0.71-0.89]), and large HDL (HR, 0.72 [95% CI, 0.59-0.89]). Although cholesterol efflux capacity was negatively associated with incident CAD, this association was no longer significant after adjustment for total HDL-P.

conclusionsLower concentrations of total HDL-P and HDL subpopulations were positively associated with incident CAD independently of HDL-cholesterol, apolipoprotein A1, and other common CVD risk factors. Extra-small HDL was a much stronger predictor of risk than the other HDLs. Our data are consistent with the proposal that extra-small HDL plays a critical role in cardioprotection in type 1 diabetes, mediated by macrophage cholesterol efflux by the ABCA1 pathway.

Indexed as

Cholesterol, HDLCoronary Artery DiseaseDiabetes Mellitus, Type 1Particle SizeAdultApolipoprotein A-IBiomarkersFemaleHumansIncidenceLipoproteins, HDLMaleMiddle AgedProportional Hazards ModelsRisk AssessmentRisk FactorsAPOA1 protein, humanApolipoprotein A-IBiomarkersCholesterol, HDLLipoproteins, HDLcalibrated ion mobility analysis, type 1 diabetesincident cardiovascular diseaseprospective cohort study

Identifiers

PMID38958152
PMCPMC11292758

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.